Dihydroflavokawin B

Overview

Dihydroflavokawin B is a selective COX-1 inhibitor with an IC 50 of 1.22 μM. Dihydroflavokawin B weakly inhibits COX-2 and 5-LOX . Dihydroflavokawin B inhibits promastigote forms of Leishmania panamensis and Leishmania braziliensis . Dihydroflavokawin B inhibits rabbit platelet aggregation induced by Arachidonic acid, platelet activating factor, and adenosine diphosphate. Dihydroflavokawin B exhibits in vitro anti-inflammatory activity. Dihydroflavokawin B can be used for the research of leishmaniasis.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > COX | Products > Signaling Pathways > Parasite

Product Information

• Catalog No.: HY-W676872
• CAS No.: 3791-76-2
• Molecular Formula: C17H18O4
• Molecular Weight: 286.33
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source